Results 211 to 220 of about 5,060,080 (299)

Expanding the Design Space for Fall Prevention in Acute Orthopedic Hospital Care: Human-Centered Design Study.

JMIR Hum Factors
Ehn M, Revenäs Å, Tobiasson H.
europepmc   +1 more source

Colours and cultures on contemporary public space design [PDF]

, 2010
Maspoli, Rossella
core  

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

Optimizing event-based neural networks on digital neuromorphic architecture: a comprehensive design space exploration. [PDF]

Front Neurosci
Xu Y, Shidqi K, van Schaik GJ, Bilgic R, Dobrita A, Wang S, Meijer R, Nembhani P, Arjmand C, Martinello P, Gebregiorgis A, Hamdioui S, Detterer P, Traferro S, Konijnenburg M, Vadivel K, Sifalakis M, Tang G, Yousefzadeh A.   +18 more
europepmc   +1 more source

Design Space Identification and Visualization for Continuous Pharmaceutical Manufacturing. [PDF]

Pharmaceutics, 2020
Diab S, Gerogiorgis DI.
europepmc   +1 more source

Deep Learning–Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah, Ioannis N. Petropoulos, Mark Stettner, Maryam Ferdousi, Uazman Alam, Nathan Efron, Ahmed Serag, Rayaz A. Malik   +7 more
wiley   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew, Maryam Kargaran, Maik Rothe, Andreas Deistung, Dietrich Stoevesandt, Walter A. Wohlgemuth, David Strube, Thomas Kendzierski, Anna Katharina Kölsch, Maurits Gerhard Abraham Heuschen, Markus Otto, Alexander Mensch   +11 more
wiley   +1 more source

Diversity-driven, efficient exploration of a MOF design space to optimize MOF properties. [PDF]

Chem Sci
Liu TW, Nguyen Q, Dieng AB, Gómez-Gualdrón DA.   +3 more
europepmc   +1 more source

Working within the Design Space: Do Our Static Process Characterization Methods Suffice? [PDF]

Pharmaceutics, 2020
von Stosch M, Schenkendorf R, Geldhof G, Varsakelis C, Mariti M, Dessoy S, Vandercammen A, Pysik A, Sanders M.   +8 more
europepmc   +1 more source